Creso Pharma


Terranueva Corporation

CNSX: TEQ


Canadian symbol: TEQ.CN
US symbol:

Currency in CAD

Valuation Measures

Market Cap (intraday) 54.11M
Enterprise Value 38.84M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 7-7.08

Trading Information

Stock Price History

Beta (5Y Monthly) -0.99
52-Week Change 3-43.18%
S&P500 52-Week Change 349.51%
52 Week High 30.2600
52 Week Low 30.0500
50-Day Moving Average 30.1249
200-Day Moving Average 30.1092

Share Statistics

Avg Vol (3 month) 317.17k
Avg Vol (10 day) 324.41k
Shares Outstanding 532.84M
Implied Shares Outstanding 6N/A
Float 31.72M
% Held by Insiders 139.88%
% Held by Institutions 10.00%
Shares Short (Mar. 14, 2021) 42.49k
Short Ratio (Mar. 14, 2021) 40.15
Short % of Float (Mar. 14, 2021) 4N/A
Short % of Shares Outstanding (Mar. 14, 2021) 40.01%
Shares Short (prior month Feb. 11, 2021) 414.11k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep. 29, 2020
Most Recent Quarter (mrq)Dec. 30, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-17.53%
Return on Equity (ttm)-769.85%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-722.29k
EBITDA -1.25M
Net Income Avi to Common (ttm)-1.94M
Diluted EPS (ttm)-0.0590
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)69.97k
Total Cash Per Share (mrq)0
Total Debt (mrq)4.8M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.31
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-994.76k
Levered Free Cash Flow (ttm)-521.43k

mrq = Most Recent Quarter
ttm = Trailing Twelve Months
yoy = Year Over Year
lfy = Last Fiscal Year
fye = Fiscal Year Ending
fy = Forward Year
Shares outstanding is taken from the most recently filed quarterly or annual report and Market Cap is calculated using shares outstanding.

Fundamentals are updated every day.
Full screen




Cannabis Market and Business News

Real-time cannabis business news from hundreds of sources. Never miss the news that matters the most.




Company News Date
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago
TEQ.CN
Terranueva
1 year ago

Analysts data is not available


Insiders transactions are updated every hour.

Major Holders

Currency in CAD
Breakdown
39.88%% of Shares Held by All Insider
0.00%% of Shares Held by Institutions
0.00%% of Float Held by Institutions
0Number of Institutions Holding Shares
Coming Soon

Search SEDAR Filings

Company Name:
Document Type:
Start Date:
End Date:

Press Releases by Terranueva Corporation


Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development

Terranueva Gets an Additional $500,000 in Financial Support From Canada Economic Development

L’ASSOMPTION, Quebec, April 07, 2021 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”), one of the 6 companies in Québec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Canada Economic Development (“CED”) has granted the Corporatio... Read More...
Terranueva Announces Changes to Its Management Team

Terranueva Announces Changes to Its Management Team

MONTREAL, Nov. 02, 2020 -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”). The Board of Directors of Terranueva announced today a new organizational structure. Mr. Peter Polatos is appointed as interim President and Chief Executive Officer for the entire organization and also becomes a director of the Company."I am deli... Read More...
Terranueva receives $500,000 in assistance from the Canada Economic Development Agency for the regions of Quebec (CED)

Terranueva receives $500,000 in assistance from the Canada Economic Development Agency for the regions of Quebec (CED)

STOCK MARKET SYMBOL: TEQ L'ASSOMPTION, QC, Oct. 5, 2020 /CNW Telbec/ - Terranueva Corporation (CSE: TEQ) ("Terranueva"), one of six Quebec companies holding a license from Health Canada to develop cannabis-based medicinal products, is pleased to announce that the CED has granted a $500,000 repayable contribution to the Company in support ... Read More...
Terranueva Obtains $500,000 in Financial Support From Economic Development Canada

Terranueva Obtains $500,000 in Financial Support From Economic Development Canada

L’ASSOMPTION, Quebec, Sept. 24, 2020 -- Corporation Terranueva (CSE : TEQ) ) (the “Corporation” or “Terranueva”), one of the 6 companies in Québec holding a licence from Health Canada to develop cannabis products for medical and recreational purposes, is pleased to announce that Economic Development Canada (“EDC”) has granted a loan of $5... Read More...
Terranueva Corporation - Licence Amendment

Terranueva Corporation – Licence Amendment

L’ASSOMPTION, Québec, Sept. 04, 2020 -- Corporation Terranueva (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has filed a licence amendment request with Health Canada to obtain the authorization to sell finished products in the retail cannabis market. Terranueva is now awaiting comments from Health Canada.Terranueva has... Read More...
Renunciation by LSL Laboratory to the Proposed Transaction with Terranueva

Renunciation by LSL Laboratory to the Proposed Transaction with Terranueva

L’ASSOMPTION, Quebec, July 15, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) and Laboratoire LSL Inc. ("Laboratoire LSL") announce that the parties have terminated their contractual relationship for the acquisition of the securities of Laboratoire LSL announced by press release on March 27, 2020.The Corpor... Read More...
Amendment of Warrants

Amendment of Warrants

L’ASSOMPTION, Québec, May 29, 2020 -- Terranueva Corporation (CSE : TEQ) (the “Corporation” or “Terranueva”) announces its intention to amend the term and exercise price of the 2,310,000 Series A warrants issued as part of a private placement which closed on December 14, 2018 (the “Warrants”). Under the current terms, each Warrant can be ... Read More...
Major Transaction With the Pharmaceutical LSL Laboratory Inc. for 23.7 Million Dollars

Major Transaction With the Pharmaceutical LSL Laboratory Inc. for 23.7 Million Dollars

L’ASSOMPTION, Quebec, March 27, 2020 -- CORPORATION TERRANUEVA (CSE : TEQ) (the “Corporation” or “Terranueva”) announces that it has reached a preliminary agreement, which became effective on March 26, 2020 following the consent of the two main creditors of Terranueva, with the owners of the pharmaceutical company LSL Laboratory Inc. (“LS... Read More...
Terranueva completes first harvest

Terranueva completes first harvest

L’ASSOMPTION, Quebec, July 17, 2019 -- Corporation Terranueva (CSE:TEQ) ("Terranueva") is pleased to announce the completion of its first harvest in its certification, research and development unit ("CRDU")."We are very pleased with the first results, the yield is higher than we expected, which allows us to confirm that our growing method... Read More...
Terranueva concludes a letter of intent with SQDC

Terranueva concludes a letter of intent with SQDC

MONTREAL, May 22, 2019 -- Terranueva Corporation (CSE: TEQ) (“Terranueva” or the “Company”) is pleased to announce the signing of a letter of intent with la Société québécoise du cannabis (SQDC) under which Terranueva will supply the SQDC with recreational cannabis for distribution and sale in the province of Quebec.Under the terms of the... Read More...
Terranueva secures option for 280,000 sq. ft. to continue expansion plans at L'Assomption

Terranueva secures option for 280,000 sq. ft. to continue expansion plans at L’Assomption

MONTRÉAL, April 15, 2019 -- Terranueva Corporation (CSE:TEQ) ("Terranueva" or the "Corporation") is pleased to announce that, following the issuance of culture, transformation and sale (medical) licenses issued by Health Canada on February 22, the Company pursued its development plan by securing contingent options to purchase over 280,000... Read More...
Terranueva Raises $278,750 Following Exercise of Rights

Terranueva Raises $278,750 Following Exercise of Rights

MONTREAL, Feb. 27, 2019 -- TERRANUEVA CORPORATION (“Terranueva”) (CSE:TEQ) announces that it has raised $278,743.04 from its rights offering (the “Rights”), which started on October 30, 2018, while holders have exercised Rights at $0.64 each to acquire an aggregate of 435,536 common shares in the capital stock of Terranueva, of which none... Read More...
Private Placement of $366,666

Private Placement of $366,666

MONTRÉAL, Feb. 19, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) is pleased to announce that it has completed a private placement for an aggregate amount of $366,666 in common shares at a price of $0.50 per share, representing an aggregate of 733 332 shares of the capital stock of Terranueva. This private placement comes ... Read More...
Terranueva Grants Options

Terranueva Grants Options

MONTRÉAL, Feb. 05, 2019 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announces the grant to its directors, officers, employees and consultants of an aggregate of 2,225,000 stock options to acquire the same number of common shares of the capital stock of the Corporation at an exercise price $0.50 per share for a period between... Read More...
Terranueva Corporation to Begin Trading on the Canadian Securities Exchange

Terranueva Corporation to Begin Trading on the Canadian Securities Exchange

MONTREAL, Dec. 17, 2018 -- TERRANUEVA CORPORATION (“Terranueva” or the “Company”) announced that its common shares (“Common Shares”) will be listed and begin trading today on the Canadian Securities Exchange (the “CSE”) under the ticker symbol “TEQ”. Terranueva Pharma is a private Québec-based Company operating in L’Assomption (Québec) th... Read More...
Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000

Closing of the Transaction of $10,930,000 with Terranueva Pharma Corporation and Concurrent Private Placement of $2,310,000

MONTREAL, Dec. 17, 2018 -- Terranueva Corporation (the “Corporation” or “Terranueva”) (TEQ.CN) is pleased to announce the closing of a private placement and of the transaction of $10 930 000 with Terranueva Pharma Corporation (“Terranueva Pharma”) consisting of a reverse takeover between the shareholders of Terranueva Pharma and Axe Explo... Read More...
Coming Soon.

Delayed data (1h)


Share this page